VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0980666
Sex: M
Age:
State: LA

Vax Date: 12/23/2020
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; headache; muscle pain; fever; nausea; running nose; This is a spontaneous report from a contactable other hcp. A 51-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:El3246, expiry date unknown), via an unspecified route of administration on 23Dec2020 at a SINGLE DOSE then (lot: El3246) via an unspecified route of administration on 13Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. The patient experienced chills, headache, muscle pain, fever, nausea and running nose on 14Jan2021. Treatment was not received for all events. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0980667
Sex: F
Age:
State: TN

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Localized redness and swelling (hard knot like) approximately the size of a half dollar; Localized redness and swelling (hard knot like) approximately the size of a half dollar; Localized redness and swelling (hard knot like) approximately the size of a half dollar; pain the arm and shoulder; pain the arm and shoulder; This is a spontaneous report received from a contactable nurse (who is also the patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142, expiry date: unknown), via an unspecified route of administration in the right arm, on 11Jan2021 07:15, at single dose, for COVID-19 immunization, in the hospital. Medical history included COVID-19 prior to vaccination. The patient has no known drug allergies and is not pregnant. Concomitant medication included ethinylestradiol, etonogestrel (NUVARING), omeprazole (PRILOSEC) and biotin. The patient did not receive other vaccine in four weeks. The patient experienced localized redness and swelling (hard knot like) approximately the size of a half dollar with continued pain the arm and shoulder on 12Jan2021. The patient was not tested for COVID-19 post vaccination. Treatment was reported as unknown. The outcome of the events was not recovered.

Other Meds: NUVARING; PRILOSEC [OMEPRAZOLE]; BIOTIN

Current Illness:

ID: 0980668
Sex: F
Age:
State: MI

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 1st shot- flushed/hot feeling a couple minutes after, only lasting minutes; 1st shot- flushed/hot feeling a couple minutes after, only lasting minutes; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: not provided), intramuscular on 18Dec2020 12:00 PM at single dose on the right arm for COVID-19 immunization. The patient is not pregnant. Medical history included Bell's palsy in 2017. No known allergies. The patient's concomitant medications were not reported. Facility type vaccine was hospital. No COVID prior vaccination. The patient reported that on the first shot on 18Dec2020, she experienced flushed/hot feeling a couple minutes after, only lasting minutes. Outcome of the events was recovered on 18Dec2020. Patient was not tested for COVID post vaccination. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0980669
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: acid reflux flare; acid reflux flare; nausea; mild headache; feeling unwell; severe fatigue; This is a spontaneous report from a non-contactable other healthcare professional reporting for herself. A 32-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EL8982, expiry date: 31May2021), via an unspecified route of administration, on 13Jan2021 03:00 PM, at a single dose on the left arm for COVID-19 immunization. Medical history included acid reflux. The patient was not pregnant and had no known allergies. The patient received the vaccine at a country vaccination drive through. Facility type vaccine was other. The patient had not received any other vaccine in four weeks prior to vaccination. Concomitant medications (other medications in two weeks) included vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), ergocalciferol (VITAMIN D [ERGOCALCIFEROL]), ubidecarenone (COQ10), zinc, and magnesium. On 13Jan2021 03:30 PM, half an hour after the vaccination, the patient experienced an acid reflux flare, nausea, mild headache, feeling unwell, and severe fatigue. The symptoms lasted for about 4 hours. The patient did not have COVID prior to vaccination and was not tested for COVID post vaccination. The patient did not receive any treatment for the reported adverse events. Outcome of the events was recovered on 13Jan2021 07:30 PM. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN B12 [CYANOCOBALAMIN]; VITAMIN D [ERGOCALCIFEROL]; ZINC; COQ 10; MAGNESIUM

Current Illness:

ID: 0980670
Sex: F
Age:
State: TX

Vax Date: 12/19/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: losing taste and smell for two days; losing taste and smell for two days; This is a spontaneous report from a contactable pharmacist. A 54-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot and expiry not reported), via an unspecified route of administration on her left arm on 19Dec2020 13:15 at a single dose for COVID-19 immunization. Medical history included known allergy to Sulfa. The patient's concomitant medications were not reported. The reaction with the first dose was losing taste and smell for two days (unknown date). The reaction with the 2nd dose was three nights of very vivid nightmares to the point of waking up with panics with worm head. This is not usual and happened the night of the vaccination (11Jan2021) and subsequent two nights. The patient did not receive treatment for the events. The outcome of the events was unknown. No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0980671
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: slight metallic taste" on the back and sides of her tongue; This is a spontaneous report from a non-contactable consumer (patient). A 41-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration in Jan2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that 15 minutes after the patient received her first dose of the Pfizer-BioNTech Covid-19 Vaccine in Jan2021, she noticed a "slight metallic taste" on the back and sides of her tongue. She wanted to know if this was a common side effect and if there have been reports regarding it. Outcome of the event was unknown. No follow-up attempts are possible; information about the lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0980672
Sex: F
Age:
State: IL

Vax Date: 12/23/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: Blood pressure; Result Unstructured Data: Test Result:went up; Comments: went up to something over 90

Allergies:

Symptoms: slightly light headed; rt hand got red & hot; rt hand got red & hot; numb, heat in rt arm/right side of jaw felt numb; Blood pressure went up to something over 90; fatigued; it hurt to open my mouth (gland by rt ear felt swollen); got a line of inflammation in my rt inside cheek; This is a spontaneous report from a contactable other HCP (patient). A 52-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number= EL0140), intramuscular at right arm on 23Dec2020 16:45 at single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication in two weeks included Multi vitamin, tocopherol (VITAMIN E), vitamin d3, bioidenticle estrogen/progesterone. The patient previously took Iodine, metronidazole (FLAGYL), Doxycycline, clarithromycin (KETEK); and known allergies to them. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt slightly light headed. Within 5 minutes right hand got red & hot, numb, heat in right arm & right side of jaw felt numb as if blew up balloons. Blood pressure went up to something over 90. The patient took a benadryl. Next few days v fatigued & on p.m. of 24th it hurt to open her mouth (gland by right ear felt swollen). The patient got a line of inflammation in her right inside cheek & a tissue mound that had not gone away. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovering.

Other Meds: VITAMIN E [TOCOPHEROL]; VITAMIN D3; PROGESTERONE

Current Illness:

ID: 0980673
Sex: F
Age:
State: LA

Vax Date: 12/23/2020
Onset Date: 01/11/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210114; Test Name: Covid-19 test; Result Unstructured Data: Test Result:Negative; Comments: Nasal Swab

Allergies:

Symptoms: small bump under left arm (not near injection site); rash appeared on both legs on upper thighs, slight itch, blotchy, red; rash appeared on both legs on upper thighs, slight itch, blotchy, red; This is a spontaneous report from a contactable consumer. A 52-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, lot number: EK9231; expiration date not provided), via an unspecified route of administration on 23Dec2020 16:00 at a single dose at left arm for COVID-19 immunisation. Medical history included seasonal allergies. Concomitant medication included desogestrel, ethinylestradiol (KARIVA) and fish oil. The patient previously took aspirin (E.C.) for gastro upset and experienced allergies. It was reported that rash appeared on both legs on upper thighs, slight itch, blotchy, red, no leg swelling or pain; no pus or discharge. On 11Jan2021, the patient had a small bump under left arm (not near injection site). The patient underwent lab tests and procedures which included SARS-COV-2 test (nasal swab) on 14Jan2021 which showed negative. The patient received hydrocortisone cream as treatment medication. The outcome of the event was recovering.

Other Meds: KARIVA; FISH OIL

Current Illness:

ID: 0980674
Sex: F
Age:
State: OK

Vax Date: 12/20/2020
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dizzy; Vertigo/room spins; This is a spontaneous report from a contactable nurse (patient herself). A 43-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on the left arm on 20Dec2020 15:00 at a single dose for COVID-19 immunization at hospital facility. The patient had no other vaccine in four weeks. Medical history included anxiety, depression, high cholesterol, tinnitus, GERD and seasonal allergies. Concomitant medications in two weeks included valaciclovir hydrochloride (VALTREX), omeprazole (PRILOSEC), iron, atorvastatin (LIPITOR), melatonin, "BCP, and daily vitamin." The patient had no COVID prior to vaccination and was not pregnant. The patient experienced vertigo/ dizzy/ room spins starting in Jan2021 (reported as 08Jan2021/09Jan2021), 1-2 days prior to 2nd vaccine (10Jan2021). The patient did not receive treatment for the events and was not COVID tested post vaccination. The outcome of events was not recovered. Information on the Lot/Batch number has been requested.

Other Meds: VALTREX; PRILOSEC [OMEPRAZOLE]; IRON; LIPITOR [ATORVASTATIN]; MELATONIN

Current Illness:

ID: 0980675
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: BP; Result Unstructured Data: Test Result:154/100 mmHg; Test Name: BP; Result Unstructured Data: Test Result:100/70 mmHg; Test Name: heart rate; Result Unstructured Data: Test Result:167 bpm

Allergies:

Symptoms: fast heart rate (167 bpm); anxious; had a warm feeling; BP was 154/100 mmHg and her baseline is 100/70 mmHg; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiry unknown), via an unspecified route of administration on 29Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient experienced an AE 5 minsutes after the dose on 29Dec2020, patient had a fast heart rate (167 bpm), was anxious, had a warm feeling, BP was 154/100 mmHg and her baseline was 100/70 mmHg. The patient would like to know if she should proceed with the second dose. The outcome of the events was unknown. Information on the Lot/Batch number has been requested

Other Meds:

Current Illness:

ID: 0980676
Sex: F
Age:
State: CA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: half of my legs feel uneasy; had bad taste like metal; This is a spontaneous report from a contactable nurse (patient). A 45-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8482, expiration date: unknown), via an unspecified route of administration on the left arm on 14Jan2021 at 12:00 at a single dose for COVID-19 immunization. Medical history included history (Hx) of blood clots. The patient has no known allergies. The patient is not pregnant. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks and no other medication in two weeks. The patient had no COVID prior vaccination and had not tested post vaccination. On 14Jan2021 at 1315, the patient experienced half of her legs felt uneasy, no pain, just like she worked out. The patient also reported that after the vaccine, she had a bad taste, like metal. No treatment was administered for the events. The events had not resolved.

Other Meds:

Current Illness:

ID: 0980677
Sex: F
Age:
State: CT

Vax Date: 01/13/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; muscle aches; headache; fatigue; nausea; didn't feel well; This is a spontaneous report from a contactable consumer. A 36-year-old female patient (pregnant: unknown) received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. No other vaccine in four weeks. The patient experienced chills, muscle aches, headache, fatigue, nausea in Jan2021 as a result of her second vaccination. The patient didn't feel well in Jan2021 after her second vaccination on 13Jan2021. It was unknown if treatment for the adverse events. No Covid prior vaccination. It was unknown if Covid tested post vaccination. The outcome of the event didn't feel well was unknown, of the other events was recovering. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 0980678
Sex: F
Age:
State: AL

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left underarm was hurting; There was a pear size lump that is very tender there. It feels fluid filled to her; There was a pear size lump that is very tender there. It feels fluid filled to her; This is a spontaneous report from a contactable nurse. A 47-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EL3302,via an unspecified route of administration in the left arm, on 12Jan2021 10:00 at SINGLE DOSE for COVID-19 immunization. Medical history sleep apnea, GERD, TMJ and depression. Historical vaccine included first dose of BNT162B2 on 22Dec2020 for COVID-19 immunization. Concomitant medication included cefixime (FLEXERIL), fluoxetine hydrochloride (PROZAC), omeprazole (PRILOSEC) and trazodone. on 13Jan2021 12:00, 24 hrs post vaccination, patient noticed that her left underarm was hurting, and she touched it. There was a pear size lump that is very tender there. It feels fluid filled to her. Therapeutic measures were taken as a result of events included an unspecified treatment and will be receiving an ultrasound. Outcome of events was not recovered. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.

Other Meds: FLEXERIL [CEFIXIME]; PROZAC; PRILOSEC [OMEPRAZOLE]; TRAZODONE

Current Illness:

ID: 0980679
Sex: F
Age:
State: FL

Vax Date: 01/05/2021
Onset Date: 01/10/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she couldn't get the words out properly when speaking with a client; she was looking at her husband and she couldn't see about a quarter of his face; This is a spontaneous report from a contactable consumer. A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EH9899, via an unspecified route of administration in the upper left arm, on 05Jan2021 08:45 at a SINGLE DOSE for covid-19 immunization. Patient had no other relevant medical history. There were no concomitant medications used. Historical vaccine included Flu vaccine. On 10Jan2021 11:51, the patient experienced that when she was looking at her husband and she couldn't see about a quarter of his face. About 10 minutes later (12:01), she couldn't get the words out properly when speaking with a client. Within five minutes or so, everything was back to normal. Outcome of events was recovered. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.

Other Meds:

Current Illness:

ID: 0980680
Sex: F
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Fatigue; swollen lymph nodes; arm soreness; This is a spontaneous report from a contactable healthcare professional. A 36-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine), intramuscular in the left arm on 08Jan2021 08:15 at a single dose for covid-19 immunisation. The patient's medical history was not reported. The patient is not pregnant. Concomitant medication included ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN). The patient previously took tamiflu and experienced allergies. On 08Jan2021 10:00, the patient experienced headache, fatigue, swollen lymph nodes and arm soreness. The patient has not tested positive for COVID post vaccination. The patient did not received treatment for the events. The outcome of the events was not recovered. Information on the Lot/batch number has been requested.

Other Meds: ORTHO TRI-CYCLEN

Current Illness:

ID: 0980681
Sex: F
Age:
State: SC

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: Covid; Result Unstructured Data: Test Result:unknown result

Allergies:

Symptoms: Dizziness; Severe migraine; Nausea; Blurred vision; This is a spontaneous report from a contactable healthcare professional (patient). A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL3246, expiry: unknown), via an unspecified route of administration in the left arm on 12Jan2021 at a single dose in the workplace clinic for COVID-19 immunization. Medical history included lupus SLE and known allergies with Stadyl. Concomitant medications included ascorbic acid (ESTER-C [ASCORBIC ACID]) and prednisone. The patient had no other vaccine in four weeks. The patient experienced severe migraine, blurred vision, dizziness and nausea on 12Jan2021 at 14:00. The patient was tested for Covid prior to vaccination but was not tested post vaccination. The events were not treated. The outcome of the events was recovering.

Other Meds: ESTER-C [ASCORBIC ACID]; PREDNISONE

Current Illness:

ID: 0980682
Sex: F
Age:
State: CA

Vax Date: 01/11/2021
Onset Date: 01/13/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Itchy; Patchy rash with pin point spot and hives with blisters all over my right lower flank and bilateral posterior proximal leg. Rash started 2 days after the initial vaccine.; Patchy rash with pin point spot and hives with blisters all over my right lower flank and bilateral posterior proximal leg. Rash started 2 days after the initial vaccine.; Patchy rash with pin point spot and hives with blisters all over my right lower flank and bilateral posterior proximal leg. Rash started 2 days after the initial vaccine.; This is a spontaneous report from a contactable other hcp. A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 11Jan2021 09:00 at a SINGLE DOSE for covid-19 immunisation. Medical history was reported as none. Concomitant medication included magnesium citrate (MAGNESIUM CITRATE), turmeric [curcuma longa rhizome] (TURMERIC [CURCUMA LONGA RHIZOME]) and Organic multi vitamin. On 13Jan2021 16:30, the patient experienced itchy, patchy rash with pin point spot and hives with blisters all over my right lower flank and bilateral posterior proximal leg. It was noted that the rash started 2 days after the initial vaccine. The outcome of the event was not recovered. Information on the lot/batch number has been requested.

Other Meds: MAGNESIUM CITRATE; TURMERIC [CURCUMA LONGA RHIZOME]

Current Illness:

ID: 0980683
Sex: F
Age:
State: KY

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Big bruise on right arm; Shoulder and tendons very sore; Shoulder and tendons very sore; This is a spontaneous report from a contactable healthcare professional (patient). A 64-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231, expiration date unknown), via an unspecified route of administration in the right arm on 05Jan2021 at 01:30 AM at a single dose for COVID-19 immunization. The patient's medical history included allergies and patient had no COVID prior to vaccination. Patient is not pregnant. The patient's concomitant medications were not reported. The patiently previously received the first dose of BNT162B2 on unspecified date for COVID-19 immunization. The patient has not had any other vaccine in four weeks and no other medications in two weeks. On 06Jan2021, the patient experienced big bruise on right arm. It was also reported that shoulder and tendons were very sore. The patient reported that it has been 10 days and it was not getting better. The patient had not been tested for COVID post vaccination. The outcome of the events was not recovered at the time of the report.

Other Meds:

Current Illness:

ID: 0980684
Sex: F
Age:
State: LA

Vax Date: 01/13/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: high itching over her whole body, itching all over even her head and hair, up and down her spine, everything; This is a spontaneous report from a contactable consumer (patient's husband). An 80-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date not reported) via an unspecified route of administration, on 13Jan2021, single dose for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. The patient experienced high itching over her whole body, itching all over even her head and hair, up and down her spine, everything in Jan2021. Outcome of the event was unknown. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0980685
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Enlarged lymph node above left collar bone; This is a spontaneous report from a contactable nurse (patient herself). A 25-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El3247, expiry date not reported), via an unspecified route of administration in the left arm on 13Jan2021 at single dose for COVID-19 immunisation. Medical history was not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included insulin aspart (NOVOLOG). The patient previously took first dose of bnt162b2 (lot number and expiry date not reported) on an unspecified date at single dose for COVID-19 immunisation. The patient had enlarged lymph node above left collar bone on 14Jan2021. Clinical outcome of the event was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: NOVOLOG

Current Illness:

ID: 0980686
Sex: F
Age:
State: TX

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash on chest and upper back; sore throat; muscle twitching around left eye; Fatigue; headache; muscle aches; swelling on left side of body including facial, arm pit, and arm down toward elbow, upper back under shoulder blade; This is a spontaneous report from a contactable nurse (patient). A 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL1284, expiration date unspecified), intramuscular on 12Jan2021, at 13:00 at single dose (left arm) for COVID-19 immunization. Medical history included Covid-19 (prior vaccination). The patient was not pregnant and had no known allergies. Concomitant medication included acetylsalicylic acid (ASPIRIN). On 12Jan2021, at 15:00, the patient experienced fatigue, headache, muscle aches, swelling on left side of body including facial, arm pit, and arm down toward elbow, and upper back under shoulder blade, rash on chest and upper back, sore throat, and muscle twitching around left eye. The patient had no treatment for the events. The patient had no other vaccine in 4 weeks; and patient was not Covid tested post vaccination. Outcome of the events was not recovered.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 0980687
Sex: M
Age:
State: OK

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210113; Test Name: body temperature; Result Unstructured Data: Test Result:Fever up to 101.8

Allergies:

Symptoms: fever (up to 101.8); mild nausea; slight fatigue; aching joints; runny nose; slight headache; breaking into sweats; injection site pain; This is a spontaneous report received from a non-contactable other healthcare professional. A 46-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176, expiry date: unknown), intramuscular in the right arm, on 13Jan2021 15:15, at single dose, for COVID-19 immunization, in the hospital. Medical history included COVID-19. The patient has no known allergies. There were no concomitant medications. The patient did not receive other medications in two weeks. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK 5730), via an unspecified route of administration in the right arm, on 23Dec2020 at 16:00, for COVID-19 immunization. On 13Jan2021 at 18:00, the patient experienced fever (up to 101.8), mild nausea, slight fatigue, aching joints, runny nose, slight headache, breaking into sweats and injection site pain. The patient did not receive treatment for the events. The patient was not tested for COVID-19 post vaccination. The outcome of the events was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0980688
Sex: M
Age:
State:

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild fever; Injection site pain; Feeling a little unwell; This is a spontaneous report from a non-contactable consumer (patient). A 52-year-old male patient received their first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: 1284, expiry date not reported), via an unspecified route of administration on the left arm on 13Jan2021 14:00 at single dose for COVID-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing (COVID prior to vaccination). There were no concomitant medications. The patient experienced mild fever on second day, injection site pain, feeling a little unwell; all unspecified dates. The outcome of the events was unknown. The patient was not covid tested post vaccination. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0980689
Sex: F
Age:
State: CA

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: at injection site redness; at injection site: redness, swelling; at injection site: redness, swelling, itchiness; at injection site: redness, swelling, itchiness, and warmth; This is a spontaneous report from a contactable healthcare professional (patient). A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 12Jan2021 17:30 at single dose for COVID-19 immunization. Medical history included allergies to oranges and pineapples and many food sensitivities and latex sensitivity from an unknown date and unknown if ongoing. Concomitant medication included clarithromycin (CLARITIN), ergocalciferol (VIT D), zinc, vitamin C and vitamin B complex. The patient previously took flexeril [cyclobenzaprine hydrochloride], naproxen and Z-pak and experienced allergies. The patient previously had first dose of BNT162b2 in left arm on 23Dec2020 for COVID-19 immunization. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 13Jan2021, the patient experienced at injection site: redness, swelling, itchiness, and warmth that continues to increase. The diameter of redness and swelling is approximately 2 inches. Half of my surrounding arm area is warm to the touch and the redness is very itchy. Other side effects have greatly diminished. The outcome of the events was not recovered. No treatment was given to the patient for the events. Information on the lot/ batch number has been requested.

Other Meds: CLARITIN [CLARITHROMYCIN]; VIT D; ZINC; VITAMIN C [ASCORBIC ACID]; VITAMIN B COMPLEX

Current Illness:

ID: 0980690
Sex: M
Age:
State: TN

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: rapid heartbeat; Result Unstructured Data: Test Result:rapid heartbeat; Test Name: tested; Test Result: Negative

Allergies:

Symptoms: chills; severe shortness of breath; rapid heartbeat; Headache; Fatigue; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 66-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1283) via intramuscular at right arm on 11Jan2021 14:00 at single dose for COVID-19 immunisation. Medical history reported as none. There were no concomitant medications. The patient previously received first dose of BNT162B2 on an unspecified date for COVID-19 immunisation and experienced sinus infection from 24Dec2020 and recovered on 31Dec2020, he went through antibiotics for a week for the sinus infection which was completed by the second dose. Patient works in a hospital laboratory. He wanted to report a reaction/side effect for Pfizer COVID 19 vaccine. Stated this was his second dose. The reaction started 12 hours post vaccination of chills that went overnight (12Jan2021). Stated that it was followed by severe shortness of breath at about 4 to 5 AM and rapid heartbeat. He was advised to get tested and was negative (undated). He also had headache and fatigue, all on 12Jan2021. Stated that he had gotten his second dose at 14:00 on 11Jan2021. Stated that he never experienced anything like on 12Jan2021 that he was literally frantic. Outcome of fatigue was recovered on 13Jan2021, outcome of other events recovered on 12Jan2021.

Other Meds:

Current Illness:

ID: 0980691
Sex: F
Age:
State: WI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chest heaviness; This is a spontaneous report from a contactable pharmacist. A 25-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EL1283, via an unspecified route of administration on 08Jan2021 at a single dose, for covid-19 immunization. Medical history included allergies from shellfish-derived products. The patient's concomitant medications were not reported. The patient experienced chest heaviness on 08Jan2021. Patient was transported to ER for evaluation. Upon re-evaluation in ER, patient felt back to baseline and was discharged. The outcome of event was recovered. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.

Other Meds:

Current Illness:

ID: 0980692
Sex: M
Age:
State: NY

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: Complete Blood Count (CBC); Result Unstructured Data: Test Result:everything was fine; Test Name: Comprehensive Metabolic Panel (CMP); Result Unstructured Data: Test Result:everything was fine

Allergies:

Symptoms: Little muscle twitches; felt muscle twitches really deep in his abdomen, almost like in the intestines; Low grade fever; Muscle soreness; Muscle tiredness; Hands were a little shaky; Very diaphoretic; This is a spontaneous report from a contactable other Nurse. This 44-year-old Nurse (Patient) reported that he received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown) at single dose for vaccination in Jan2021 around 9:45am. Relevant medical history included ongoing Mild shrimp allergy and ongoing Hypertension. Relevant concomitant drugs included amlodipine at 10 mg once daily for Hypertension since Feb2020 and ongoing. Prior Vaccinations (within 4 weeks): None. Family Medical History Relevant to AE(s) was None. The patient was administered the COVID Vaccine around 9:45am; about 10 minutes later he had onset of little muscle twitches on the left side of his body that started in the calf then the glute, then the quadricep, then the bicep and then just started bouncing around everywhere on left side. Approximately a half an hour after that those little muscle twitches started on the right side of his body. Now the little muscle twitches are just everywhere; his hand, his heel, right now as he is speaking he is having the little muscle twitches in his heel; This event has been ongoing since onset; but changed today around 5:00am when he felt muscle twitches really deep in his abdomen, almost like in the intestines which is probably impossible, but it feels like it is not just muscular now, like it is happening in his intestines which concerns him. The little muscle twitches do not hurt, he thinks that is probably why he has waited a week to call; but the fact that they are ongoing and changed today, worsened is unsettling. He reported since that first dose of COVID Vaccine was administered he has also had low grade fever; muscle soreness; muscle tiredness. He reported that a rapid response team was called immediately because of the initial reaction he had. Later that day his hands were a little shaky, he got very diaphoretic and the nurses on the unit of the hospital said he almost fell which he does not recall at all; in response to those events he was taken to the emergency department where they did a complete workup including labs: Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), checked his heart and everything was fine; no notable results from any of those tests. The patient was not admitted to the hospital; under observation in emergency room only. Outcome of events Little muscle twitches, Low grade fever, Muscle soreness and Muscle soreness was not resolved, outcome of other events was unknown. Information about lot/batch number has been requested.

Other Meds: AMLODIPINE

Current Illness: Hypertension; Shellfish allergy

ID: 0980693
Sex: F
Age:
State: FL

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain in the thigh muscle; terrible pain in her leg and in her thigh/arm was feeling a little sore/ache in arm; a lot of pain; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from Jan2021 to Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient stated that she got the Pfizer Vaccine on Tuesday and she have now a terrible pain in her leg and in her thigh, pain in the thigh muscle, it is very, very painful. She had a little ache in arm, nothing terrible. She also stated that She felt fine except her arm was feeling a little sore. Last night, she got terrific pain in her thigh muscle and she is in a lot of pain. Outcome of the events was unknown. Information on lot/batch number has been requested..

Other Meds:

Current Illness:

ID: 0980694
Sex: M
Age:
State: WI

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Transient global amnesia; This is a spontaneous report from a contactable physician. A 71-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL0142, expiration date not reported), intramuscular on the left arm, from 07Jan2021 at 09:00 at a single dose for Covid-19 immunization. Medical history included low back pain, benign prostatic hyperplasia, impaired fasting glucose. Concomitant medications included hydrochlorothiazide (HCTZ), lisinopril, and tamsulosin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 07Jan2021, the patient experienced transient global amnesia. Started about 4-5 hours after vaccination and lasted 12 hours. There was no treatment received for the event. Outcome of the event was recovered on 07Jan2021. The reporter assessed the event as non-serious.

Other Meds: HCTZ; LISINOPRIL; TAMSULOSIN

Current Illness:

ID: 0980695
Sex: F
Age:
State: NY

Vax Date: 01/12/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: It's an idiosyncratic reaction that happens periodically; flushing; palpitations; shaking chills (violent shaking); difficulty breathing; This is a spontaneous report from a contactable pharmacist. A 58-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, lot number: EL3246; expiration date not provided), via an unspecified route of administration on 12Jan2021 16:30 at a single dose at left arm for COVID-19 immunisation, glatiramer acetate (COPAXONE), via an unspecified route of administration from an unspecified date at an unknown dose and frequency for unspecified indication. Medical history included multiple sclerosis, hypothyroidism and osteoporosis. The patient was not pregnant. The patient received the first dose of BNT162B2 (lot number: EKS730) on 22Dec2020. The evening after the patient had her second Covid vaccine, the patient gave herself Copaxone shot. On 14Jan2021, the patient stated that there was an idiosyncratic reaction that happens periodically. Symptoms were flushing and palpitations. It ends quickly. About 15 minutes after that occurred, the patient had shaking chills (violent shaking) and difficulty breathing. The symptoms lasted about 1 hour. During that hour, the patient had someone drive her to the hospital but during the drive the symptoms calmed down. The patient spoke with one of the nurses that does screening in the lobby and they said many people had been reacting to their second shots, so she didn't really need to be seen in the ED since her symptoms had resolved. No treatment was received. The action taken in response to the event for glatiramer acetate was unknown. The outcome of the events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0980696
Sex: F
Age:
State: MI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Panic; Anxiety; Vertigo; Flushing feeling; Tachycardia; This is a spontaneous report from a contactable nurse (patient). A 45-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number El01Y0, expiration date not reported), intramuscular on the left arm, on 08Jan2021 at 10:30, single dose for Covid-19 immunization. The patient has no medical history and no concomitant medications. The patient previously took the first dose of bnt162b2 (Lot number: EJ1685), intramuscular on the right arm, on 18Dec2020 at 10:00 AM for Covid-19 immunization. The patient is not pregnant at the time of vaccination. Patient has no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 08Jan2021, at 10:35, the patient experienced flushing feeling with tachycardia 5 minutes post vaccine. On 15Jan2021, she is day 7 post vaccine and experiencing panic/anxiety, tachycardia, and vertigo type feelings. Since the vaccination, the patient has not been tested for COVID-19. The patient received treatment (prescription/monitoring) for the events. The outcome of the events was not recovered. The reporter assessed the events as non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0980697
Sex: F
Age:
State: GA

Vax Date: 01/12/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash and itching on torso and neck; Rash and itching on torso and neck; This is a spontaneous report from a contactable physician who reported for herself, a 53-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL0140) at the hospital, via an unspecified route of administration in the left arm, on 12Jan2021 at 09:15 at the age of 53 years, at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient had no COVID prior vaccination, and was not COVID tested post vaccination. The patient was not pregnant. Concomitant medications included ospemifene (OSPHENA), vitamins and ibuprofen (ADVIL). Patient had no other vaccines in four weeks. The patient previously took and had known allergies to Gentamycin Opath Drops and hydroxychloroquine. The patient received the first dose of BNT162B2 with lot number: EJ1685 at the age of 53 years, in the left arm on 21Dec2020 at 07:00 PM for COVID-19 immunization. The patient experienced rash and itching on torso and neck 48 hours after injection on 14Jan2021 at 20:00. Therapeutic measures taken as a result of rash and itching on torso and neck included Benadryl. The outcome of the events was not recovered.

Other Meds: OSPHENA; ADVIL [IBUPROFEN]

Current Illness:

ID: 0980698
Sex: F
Age:
State: AZ

Vax Date: 12/21/2020
Onset Date: 12/23/2020
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20201223; Test Name: body temperature; Result Unstructured Data: Test Result:fever

Allergies:

Symptoms: blurred vision that lasted nearly two weeks; Headache; bedridden due dizziness; bedridden due dizziness; extreme debilitating aches and pains; body felt numb; fever; chills; This is a spontaneous report received from a contactable nurse (who is also the patient). A 69-year-old female patient received the first dose of BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, lot number: RH9899, expiry date: unknown), intramuscular in left arm, on 21Dec2020 09:30, at single dose, for COVID-19 immunization. Medical history included allergies to shellfish and bee stings. There were no concomitant medications. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and is not pregnant. On 23Dec2020 at 20:00, the patient experienced headache, blurred vision that lasted nearly two weeks, extreme debilitating aches and pains, body felt numb, bedridden due dizziness, fever and chills. Treatment for the events included ibuprofen (ADVIL). The patient was not tested for COVID-19 since the vaccination. The outcome of the events was recovered on an unspecified date. The reporter assessed this case as non-serious.

Other Meds:

Current Illness:

ID: 0980699
Sex: F
Age:
State: CO

Vax Date: 01/13/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210113; Test Name: Resting heart rate; Result Unstructured Data: Test Result:136; Test Date: 202101; Test Name: Resting heart rate; Result Unstructured Data: Test Result:133; Test Date: 202101; Test Name: Resting heart rate; Result Unstructured Data: Test Result:105; Test Date: 202101; Test Name: Resting heart rate; Result Unstructured Data: Test Result:below 100; Test Date: 202101; Test Name: lot of test; Result Unstructured Data: Test Result:ruled out nothing

Allergies:

Symptoms: Went to hospital in middle of night when resting heart rate was 136/ woke up in middle of night with racing heart/was 133; chills; fever; body aches; swollen axillary lymph nodes; rash on shoulder, armpit and back close to the vaccine site; bad headache; This is a spontaneous report from a contactable nurse. A 40-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular (left arm) from 13Jan2021 10:45 to 13Jan2021 10:45 at a single dose for covid-19 immunization. Medical history included asthma and hypothyroidism. Concomitant medication included beclometasone dipropionate (QVAR) and levothyroxine. The patient also has allergies to Codeine and Azithromycin. The patient took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Dec2020. Information on the lot/batch number has been requested. It was reported that the patient went to the hospital (Emergency Room/Urgent Care) in the middle of the night when her resting heart rate was 136 on 13Jan2021. She had fever, chills, body aches. She woke up in the middle of the night with racing heart. Was 133 in the hospital, they gave her 2 liters of fluids which eventually brought it down to 105. They ran a lot of test and ruled out anything else. On Jan2021, they also found swollen axillary lymph nodes. It's now 48 hours later, still have a fever, HR finally is below 100, she now has a rash on her shoulder, armpit and back close to the vaccine site and she have a bad headache. The outcome of the event fever was not recovered while recovered with sequel on unspecified dates for the other events.

Other Meds: QVAR; LEVOTHYROXINE

Current Illness:

ID: 0980700
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; fatigue; joint pain; left supraclavicular lymphadenopathy; This is a spontaneous report from a non-contactable physician. A 30-year-old female patient second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left arm, on an unspecified date at a SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. The patient experienced Headache, fatigue, joint pain, and left supraclavicular lymphadenopathy on an unspecified date. The outcome of events was recovering. Therapeutic measures were taken as a result of headache and joint pain included OTC pain relievers. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0980701
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she had an allergic reaction to the Prevnar 13; This is a spontaneous report from a contactable consumer (reported for herself). A female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for immunization. Caller wanted to know if the Covid vaccine had similar components as the Prevnar 13 vaccine. Caller stated that she had an allergic reaction to the Prevnar 13 vaccine in the past and had to go to the hospital to receive a shot. The outcome of the event was unknown. No Follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0980702
Sex: F
Age:
State: NJ

Vax Date: 12/21/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swelling on injection site for the first pfizer covid vaccine, it was red; swelling on injection site for the first pfizer covid vaccine, it was red; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received 1st dose of BNT162B2 (lot# EH9899), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. Medical history was none. Concomitant medications was not reported. On an unspecified date, she did experience swelling on injection site for the first pfizer covid vaccine, it was red. They had her draw a circle around it and monitor that it did not expand out of the circle. It did not and went down on its own. The outcome of events was recovered.

Other Meds:

Current Illness:

ID: 0980703
Sex: F
Age:
State: MO

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:101.3; Comments: at 6am; Test Name: fever; Result Unstructured Data: Test Result:99

Allergies:

Symptoms: fever; hip pain; 'pretty intense joint pain, felt like it was on fire; She feels ''like death today"/she did not feel good; Chills; This is a spontaneous report from a contactable nurse. A 44-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL3248) intramuscular on 14Jan2021 single dose for COVID-19 immunisation. Vaccine location was deltoid left. No other vaccine was received in four weeks. The patient medical history was not reported. Historical vaccine included first dose of BNT162B2 (Lot: EL1284) received on 28Dec2020 around 7pm, intramuscular injection right deltoid. There were no concomitant medications. The patient experienced fever (she woke up with a fever of 101.3 at 6am), pretty intense 'joint pain, felt like it was on fire' on 14Jan2021; with the first dose of the covid vaccine she had really bad hip pain about 24 hours after (as reported) and it lasted about 12 hours but she could still walk and move, it was just annoying. The patient was ''like death today"/ she did not feel good' on 14Jan2021, chills on 14Jan2021. Her temperature has improved and it is around 99. The outcome of fever and chills was recovering, of 'pretty intense joint pain, felt like it was on fire' was recovered on 15Jan2021, of she feels 'like death today'/ she did not feel good and hip pain was unknown.; Sender's Comments: A possible contributory effect of suspect BNT12B2 on reported fever cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0980704
Sex: F
Age:
State: MI

Vax Date: 12/29/2020
Onset Date: 01/10/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210113; Test Name: Rapid COVID Test; Test Result: Negative

Allergies:

Symptoms: Rash under the skin that is itchy; Rash under the skin that is itchy; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142), via an unspecified route of administration on the left arm on 29Dec2020 09:00 at a single dose for COVID-19 immunization. Medical history included ongoing blood pressure high, ongoing diabetic, and metal and copper allergies. Concomitant medication included unspecified regular medications. No other vaccines were administered on the same date. No vaccinations were received four weeks prior. On 10Jan2021 23:00, the patient reported that she broke out in a rash under her skin that was so itchy. She noticed the rash around 11PM and had been taking Benadryl around the clock. She can still see the rash on her skin, it was not raised or bumpy, but it itches like crazy. She clarified the rash was located on both of her arms, trunk, chest, back, and neck. She believed the COVID-19 vaccine was related to the rash that was itchy that she was having. She cannot think of anything she has done differently to cause this itching. It started Sunday and at the time of reporting, it was Thursday and she still had it. She stated she was trying to go to the doctor to be looked at, but no one called her back. She has been taking Benadryl around the clock from the beginning of when it was needed. It seemed like the Benadryl has not phased her at all as she was wide awake. The next dose was scheduled for Monday 18Jan2021 and she did not know if she wanted to get the second dose of the vaccine. The vaccine was given at a hospital, not military facility. The adverse events did not require a visit to the emergency room or to the physician's office. The patient underwent lab tests and procedures which included rapid COVID test: negative on 13Jan2021. Outcome of the events was recovering. The events were reported as non-serious and related to the suspect drug.

Other Meds:

Current Illness: Blood pressure high; Diabetic

ID: 0980705
Sex: F
Age:
State: CT

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: crawling on her hands and knees as well; horrific neck issue; This is a spontaneous report from a contactable physician (Specialty: Obstetrics & Gynecology). This physician reported for a patient (Reporter's friend) that: A female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not provided), via an unspecified route of administration on an unspecified date in Jan2021 at single dose for COVID-19 immunization. Medical history included minor lower back issues from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical Vaccine included first dose of BNT162B2 for COVID-19 immunization with no adverse events. The patient has a horrific neck issue in Jan2021. She got the second dose of the Pfizer COVID19 vaccine on Friday and over the weekend in Jan2021 she was crawling on her hands and knees as well. The outcome of the events was unknown Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0980706
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: COVID; Result Unstructured Data: Test Result:+; Comments: since receiving the first dose

Allergies:

Symptoms: Covid + since receiving the first dose; Covid + since receiving the first dose; This is a spontaneous report from a contactable nurse. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included near end of life (patient was transitioned to hospice). The patient's concomitant medications were not reported. Per second (2nd) vaccination clinic on 12Jan2021, it was reported the one resident was transitioned to hospice (and is near end of life) and also reported was COVID positive (+) since receiving the first dose on an unspecified date. The outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event COVID positive (+) based on the known safety profile. However the short duration since the vaccine first dose is given it is unlikely patient would have fully developed immunity.

Other Meds:

Current Illness:

ID: 0980707
Sex: F
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/12/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: CT; Result Unstructured Data: Test Result:ruled out Mastoiditis

Allergies:

Symptoms: Swelling behind left ear. Mastoiditis ruled out by CT; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 08Jan2021 at 15:30 (at the age of 55-years-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took tetracycline hcl (MANUFACTURER UNKNOWN) and thimerosal (MANUFACTURER UNKNOWN); both on unknown dates for unknown indications and experienced drug allergy. On 12Jan2021 at 06:00, the patient experienced swelling behind left ear. The event required a visit to the emergency room and physician's office. A computed tomogram in Jan2021 ruled out mastoiditis. The patient was started on antibiotics to see if the swelling would resolve. The clinical outcome of the swelling behind the left ear was not recovered. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0980708
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: contracted covid; Result Unstructured Data: Test Result:contracted covid; Comments: contracted covid after receiving the 1st vaccine dose

Allergies:

Symptoms: contracted covid after receiving the 1st vaccine dose; contracted covid after receiving the 1st vaccine dose; This is a spontaneous report from contactable nurse. This Nurse reported same events for six patients. This report is for 1st of six reports. A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 22Dec2020 at a single dose in the nursing home for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient contracted COVID after receiving the 1st vaccine dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 22Dec2020, and contracted COVID on an unspecified date. No complete effect of the suspect vaccine could be reasonably achieved from first dose to protect from the targeted infection. Further information like COVID infection date needed for a full meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021035080 same reporter/drug/event, different patient;US-PFIZER INC-2021035079 same reporter/drug/event, different patient;US-PFIZER INC-2021035081 same reporter/drug/event, different patient;US-PFIZER INC-2021035082 same reporter/drug/event, different patient;US-PFIZER INC-2021035083 same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 0980709
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: contracted COVID; Result Unstructured Data: Test Result:contracted covid; Comments: contracted covid after receiving the 1st vaccine dose

Allergies:

Symptoms: contracted covid after receiving the 1st vaccine dose; contracted covid after receiving the 1st vaccine dose; This is a spontaneous report from a contactable nurse. This nurse reported same events for six patients. This is the second of six reports. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on 22Dec2020 at a single dose in the nursing home for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient contracted covid after receiving the 1st vaccine dose. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The PFIZER-BIONTECH COVID-19 VACCINE provides protection after 7 days from the second dose.,Linked Report(s) : US-PFIZER INC-2021035078 same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 0980710
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: contracted covid; Result Unstructured Data: Test Result:contracted covid; Comments: contracted covid after receiving the 1st vaccine dose

Allergies:

Symptoms: contracted covid after receiving the 1st vaccine dose; contracted covid after receiving the 1st vaccine dose; This is spontaneous report from a contactable nurse. This nurse reported similar events for 6 patients. This is 4th of 6 reports. An unknown age and gender patient received first dose of BNT162B2 (Pfizer BioNTech Covid 19 vaccine) on 22Dec2020 at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. It was reported that patient contracted COVID after receiving the 1st vaccine dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 22Dec2020, and contracted COVID on an unspecified date. No complete effect of the suspect vaccine could be reasonably achieved from first dose to protect from the targeted infection. Further information like COVID infection date needed for a full meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021035078 same reporter/product/event, different patient

Other Meds:

Current Illness:

ID: 0980711
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: COVID; Result Unstructured Data: Test Result:contracted COVID after receiving the 1st vaccine

Allergies:

Symptoms: contracted covid after receiving the 1st dose and were still symptomatic; contracted covid after receiving the 1st dose and were still symptomatic; This is spontaneous report from a contactable nurse via Pfizer sales representative. This nurse reported similar events for 6 patients. This is the sixth of six reports. A patient of unknown age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on 22Dec2020 at single dose in the nursing home for COVID-19 immunization. Medical history and concomitant drugs were not reported. On an unspecified date, patient contracted covid after receiving the 1st dose and were still symptomatic and was unable to receive their 2nd dose on 12Jan2021. Outcome of events was not recovered. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 cannot be completely excluded. However, it is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.,Linked Report(s) : US-PFIZER INC-2021035078 same reporter/product/event, different patient

Other Meds:

Current Illness:

ID: 0980712
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: Recent COVID + diagnosis/Covid exposure; Recent COVID + diagnosis/Covid exposure; This is a spontaneous report from two contactable nurses via a Pfizer sales representative. This author reported similar events for 4 patients. This is 1st of 4 reports. A patient of unspecified age and gender receive 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient had been vaccinated with a 1st dose and had to defer to 02Feb2021 due to recent COVID + diagnosis/COVID exposure. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be excluded for reported events.,Linked Report(s) : US-PFIZER INC-2021035087 the same reporter, product and adverse events in different patients;US-PFIZER INC-2021035086 the same reporter, product and adverse events in different patients;US-PFIZER INC-2021035085 the same reporter, product and adverse events in different patients

Other Meds:

Current Illness:

ID: 0980713
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: COVID + diagnosis/Covid exposure; COVID + diagnosis/Covid exposure; This is a spontaneous report from contactable nurses. This nurse reported same events for 4 patients. This is 2nd of 4 reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that 4 employees that had been vaccinated with a 1st dose had to defer to 02Feb2021 due to recent COVID + diagnosis/Covid exposure. Lab test included positive covid test. The outcome of events was unknown. Information on the lot/batch number has been requested; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.,Linked Report(s) : US-PFIZER INC-2021035084 the same reporter, product and adverse events in different patients

Other Meds:

Current Illness:

ID: 0980714
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: Covid test; Test Result: Positive

Allergies:

Symptoms: recent COVID + diagnosis/Covid exposure; recent COVID + diagnosis/Covid exposure; This is a spontaneous report from contactable nurses. This nurse reported similar events for 4 patients. This is the third of four reports. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 22Dec2020 for COVID-19 immunisation. Medical history and concomitant medication were not reported. Reporter stated 4 employees that had been vaccinated with a 1st dose had to defer to 02Feb2021 due to recent COVID + diagnosis/COVID exposure. Event took place after use of product. Covid test was positive. The outcome of events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 cannot be completely excluded. However, it is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.,Linked Report(s) : US-PFIZER INC-2021035084 the same reporter, product and adverse events in different patients

Other Meds:

Current Illness:

ID: 0980715
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Recent COVID + diagnosis/Covid exposure; Recent COVID + diagnosis/Covid exposure; This is a spontaneous report from contactable nurses. This nurse reported same events for 4 patients. This is 4th of 4 reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that 4 employees that had been vaccinated with a 1st dose had to defer to 02Feb2021 due to recent COVID + diagnosis/Covid exposure. The outcome of events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be completely excluded for reported events.,Linked Report(s) : US-PFIZER INC-2021035084 same reporter, product and adverse events in different patients

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm